The kinetic origins of the restriction point in the mammalian cell cycle

Cell Proliferation

Volumn 32, Issue 5, 1999, Pages 321-335

  Aguda, B D ^a   Tang, Y ^a  

^a LAURENTIAN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN E; MITOGENIC AGENT; PROTEIN P27; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CHEMICAL REACTION KINETICS; COMPUTER SIMULATION; HUMAN; HUMAN CELL; MAMMAL CELL; MITOSIS; NONHUMAN; POSITIVE FEEDBACK;

EID: 0033453231     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.1999.3250321.x     Document Type: Article

References (46)

1. AGUDA BD. (1999) Instabilities in phosphorylation-dephosphorylation cascades and cell cycle checkpoints. Oncogene 18, 2846.
2. INK4a and of hypophosphorylated retinoblastoma family proteins. EMBO J. 16, 5322.
3. ALMASAN A, YIN Y, KELLY RE et al. (1995) Deficiency of pRb leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc. Natl. Acad. Sci. USA 92, 5436.
4. BARTER J, BARTKOVA J, LUKAS J. (1996) The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8, 805.
5. BARTER J, BARTKOVA J, LUKAS J. (1997) The retinoblastoma protein pathway in cell cycle control and cancer. Exptl. Cell Res. 237, 1.
6. BERNARDS R. (1997) E2F: a nodal point in cell cycle regulation. Biochim. Biophys. Acta 1333, M33.
7. CAMPANERO MR, FLEMINGTON EK. (1997) Regulation of E2F through ubiquitin-proteosome-dependent degradation: stabilization by the pRB tumor suppressor protein. Proc. Natl. Acad. Sci. USA 94, 2221.
8. COATS S, FLANAGAN WM, NOURSE J, ROBERTS JM. (1996) Requirement of p27Kip1 for R point control of the fibroblast cell cycle. Science 272, 877.
9. FANG X, JIN X, XU H-J et al. (1998) Expression of p16 induces transcriptional downregulation of the RB gene. Oncogene 16, 1.
10. FEINBERG M, HORN FJM. (1974) Dynamics of open chemical systems and the algebraic structure of the underlying reaction network. Chem. Eng. Sci. 29, 775.
11. GALAKTIONOV K, CHEN X, BEACH D. (1996) Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382, 511.
12. GENG Y, Ng EATON E, PICON M et al. (1996) Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12, 1173.
13. HENGST L, REED SI. (1996) Translational control of p27Kip1 accumulation during the cell cycle. Science 271, 1861.
14. HERRERA RE, SAH VP, WILLIAMS BO, MAKELA TP, WEINBERG RA, JACKS T. (1996) Altered cell cycle kinetics. gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16, 2402.
15. HIEBERT SW, LIPP M, NEVINS JR. (1989) E1A-dependent transctivation of the human MYC promoter is mediated by the E2F factor. Proc. Natl. Acad. Sci. USA 86, 3594.
16. HOFFMANN I, DRAETTA G, KARSENTI E. (1994) Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J. 13, 4302.
17. IKEDA M, JAKOI L, NEVINS JR. (1996) A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA 93, 3215.
18. KOFF A, GIORDANO A, DESAI D et al. (1992) Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257, 1689.
19. KOHN KW. (1998) Functional capabilities of molecular network components controlling the mammalian G1/S cell cycle phase transition. Oncogene 16, 1065.
20. KREK W, EWEN ME, SHIRODKAR S, ARANY Z, KAELIN WG, LIVINGSTON DM. (1994) Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78, 161.
21. LEONE G, DEGREGORI J, SEARS R, JAKOI L, NEVINS JR. (1997) Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387, 422.
22. LEONE G, DEGREGORI J, JAKOI L, COOK JG, NEVINS JR. (1999) Collaborative role of E2F transcriptional activity and G1 cyclin-dependent kinase activity in the induction of S phase. Proc. Natl. Acad. Sci. USA 96, 6626.
23. LI Y, NICHOLS MA, SHAY JW, XIONG Y. (1994) Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res. 54, 6078.
24. LUKAS J, HERZINGER T, HANSEN K et al. (1997) Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev. 11, 1479.
25. LUNDBERG AS, WEINBERG RA. (1998) Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Molec. Cell. Biol. 18, 753.
26. MITTNACHT S. (1998) Control of pRB phosphorylation. Curr. Opin. Gen. Dev. 8, 21.
27. MOROY T. (1998) Restriction point control in human cancer. Tumordiagn. U. Ther. 19, 93.
28. NEUMAN E, FLEMINGTON EK, SELLERS WR, KAELIN WG JR. (1994) Transcription of the E2F1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol. Cell. Biol. 14, 6607.
29. OBEYESEKERE MN, KNUDSEN ES, WANG JYJ, ZIMMERMAN SO. (1997) A mathematical model of the regulation of the G1 phase of Rb+/+ and Rb-/- mouse embryonic fibroblasts and an osteosarcoma cell line. Cell Prolif. 30, 171.
30. OHTANI K, DEGREGORI J, NEVINS JR. (1995) Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA 92, 12146.
31. PARDEE AB. (1974) A restriction point for control of normal animal cell proliferation. Proc. Natl. Acad. Sci. USA 71, 1286.
32. PARDEE AB (1989). G1 events and regulation of cell proliferation. Science 246, 603.
33. POON RYC, CHAU MS, YAMASHITA K, HUNTER T. (1997) The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res. 57, 5168.
34. REED SI. (1996) Cyclin E: in mid-cycle. Biochim. Biophys. Acta 1287, 151.
35. ROUSSEL MF. (1998) Key effectors of signal transduction and G1 progression. Adv. Cancer Res. 74, 1.
36. INK4a. Exptl. Cell Res. 237, 7.
37. SEXL V, DIEHL JA, SHERR CJ, ASHMUN R, BEACH D, ROUSSEL MF. (1999) A rate limiting function of Cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2. Oncogene 18, 573.
38. SHEAFF RJ. (1997) Regulation of mammalian cyclin-dependent kinase 2. In: Dunphy WG, ed. Cell Cycle Control (Methods in Enzymology, Vol 283). New York: Academic Press, 173.
39. SHEAFF RJ, GROUDINE M, GORDON M, ROBERTS JM, CLURMAN BE. (1997) Cyclin E-CDK2 is a regulator of p27. Genes Dev. 11, 1464.
40. TAKUWA N, TAKUWA Y. (1996) Signal transduction of cell-cycle regulation: its temporospacial architecture. Jap. J. Physiol. 46, 431.
41. TAKUWA N, TAKUWA Y. (1997) Ras activity late in G1 phase required for p27Kip1 downregulation, passage through the Restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol. 17, 5348.
42. THALMEIER K, SYNOVZIK H, MERTZ R, WINNACKER EL, LIPP M. (1989) Nuclear factor E2F mediates basic transcription and transactivation by E1A of the human MYC promoter. Genes Dev. 3, 527.
43. TSIHLIAS J, KAPUSTA L, SLINGERLAND J. (1999) The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu. Rev. Med. 50, 401.
44. Kip1. EMBO J. 16, 5334.
45. ZETTERBERO A, LARSSON O. (1985) Kinetic analysis of regulatory events in G1 leading to proliferation or quiescence of Swiss 3T3 cells. Proc. Natl. Acad. Sci. USA 82, 5365.
46. ZETTERBERG A, LARSSON O, WIMAN KG. (1995) What is the restriction point? Curr. Opin. Cell Biol. 7, 835.